Member Info for PlantPower

@Dave 77 - not sure if below is also the evaluation lab referenced in Aug RNS, expect one off the same, eg evaluate at clinical lab you’re going to use:

“...with initial introduction in the USA at an already identified clinical laboratory”

Regarding if reg approvals required or not - below stated in yesterday’s RNS, so infers maybe they are required but is this inclusive of saliva and swab - or just saliva:

“ We will obtain regulatory approvals prior to a final solution release."

Lots of questions - bring out Poirot & Elizabeth Fletcher..

Good point Invest4theLT that if 2 weeks was ‘true’ then you would expect they are further down the line now.

I know timescales has caused ‘pressure’ and can see why this may be avoided going forwards, but if for swabs there is no reg dependencies and solely in GDR / BC’s hands I would expect some timescales for investors to digest even if element of sandbagging built in.

The 2 week reference seems slightly unbelievable in my eyes - would they really take 2 weeks finessing language for an RNS (that’s not great if so).

I personally believe (I know to the contrary of company PR..) that DB’s hand was forced....I mentioned yesterday that I posted a link to the updated instructions which referenced BC kit validation that MOILY highlighted on twitter, I think that might have been trigger and maybe plan was to wait a few weeks...who knows, I’ll leave it there.

My concern is BC saliva could drag on, as clearly difficult for good reason, so mentioned before I hope the progress swab automation and get machines evaluated / validated and crack on with initial production sales with saliva being the cherry on cake to take this to the next level.

I expect evaluation lab can self certify test without FDA approval, so hopefully no external dependencies (other than BC), but may be wrong.

I feel per previous post India is close and really needs to land to take pressure off above or if not can see us sliding back (if only for 2-4 weeks) prior to BC further news / FDA / WHO approval. There is also the year end / annual update due, which is maybe what DB was waiting for, but again, not expecting anything material.

So feel we need India - or more short term pain.

Long term still confident, but I too am getting a bit impatient.

PP

Take your point Rookie - but my use of imminent (if that’s part of your reference) is in relation to India approval, and I personally feel things have changed materially in past few weeks:

- DIVOC gets lab approval from regulatory body in India
- KK tweets they are on the cusp of processing 1st sample Covid tests...
- GDR major shareholder and ex CFO congratulates KK on achievement and wishes “good luck getting the kit and schedules up and running”

PP

3 happy thoughts:

- India approvals imminent (1st major sales will accompany - expect £1m preorder subsidised by GHIF)
- PCR mass swab automation a ‘go’ pending lab evaluation (being setup)
- PCR mass SALIVA automation progressing

It’s all vegan gravy boys & gals.

#PeacePlantsPatience

Fair enough - good luck Johnboy

2.4m vol - PEEL smashing bid all day, lots of round chunky sells and lots of delayed large sells from yesterday just printed.

Expect InterTrader out early next week, end at latest.

Still destined for big things - narrative unchanged.

PP

Beats 90p 2 weeks ago!

....what a guy.

Cheers Johnboy - love ya

ADVFN 2,033,998

2mill vol though - positive from today, another chunk from II seller portfolio.

PP

Johnnyboy’s back - hello chap, always a pleasure, still got that GDR bug you can’t quite shift.

Toodlepip

1.6m vol - at least churning through those sells

Bang on foxy - I concur.

I do have a theory that RNS was released due to instructions being uploaded and made publicly available (possibly in error) and shared / highlighted on social media, maybe DB was holding back to year-end update or to allow further progress to be made.

Either way - good progress, just more, much more, to come.

PP

@flushfrank - NYCT swab (nasal / throat)....saliva = spit..holy grail

Ok - bungee time

129.8’s paid

....it’s back, let’s see what bounce we get...

PP

Turns out the update of the doc on their website was more than a clue...!

PP